Replies to post #673891 on NorthWest Biotherapeutics Inc (NWBO)

[Smitty5150]

Finally someone who speaks the truth based on facts and experience. Not pipe dreams.

Good post. NW will be sold, and for far less than what some investors here think. $15-25b.

[ilovetech]

hyperopia -

One year, 4 companies that I owned were bought out, which I had not planned for, and I got crushed by taxes

Were the four you held sold as short or long term gains? Just wondering.

[LTR]

You said you got crushed by taxes when the four companies you held got bought out. Is that because you sold the shares after the buyout news but before the buy out occurred? What if you held on to your shares, never sold, and stayed through the conversion of your shares to shares of the "new"/buy out company? Would you then avoid the tax burden? Or are you not given a choice in how to navigate this situation?

[beartrap12]

Very good comments, hyperopia. I think we're close to the same hopes for NWBO. I don't want a low-ball buyout or a company that will shelve or slow-walk DCVax or one that doesn't want a cure, at all, just maintenance drugs. Eventually, perhaps I would be ok with a merger that puts NWBO on equal ground with the other company, perhaps 3-5 years from now, so we all have an idea what we're actually worth. By then, we may have laid down the groundwork for a hub and spoke company that can continue after the buyout/merger.
But I think working as a hub with a few pharmas would be a way of bringing the talent quickly to us. The other companies would do the work of setting up the necessary clinical trials, while we continue to develop DCV-direct and improve DCVax-L and reap the financial benefits of not only our own sales, but also of selling our products to these pharmas and their doctors. If other companies want to make money curing cancer, they will do what's necessary to get their products into combo-trials with DCVax, including bringing in the money and people necessary to make it happen.
Frankly, I don't think we will have trouble hiring talented people to help develop us as a hub for cancer treatments and to grow the company quickly. Remember, Linda said "franchise" and I see that as pharmas setting up licenses with us to sell our product along side theirs, not licenses with hospitals for EDEN units, as someone here suggested.